Phyrago Tablet
Product Images NDC 70709-151

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Phyrago (NDC 70709-151). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cycle Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Untitled)

FDA Label Image

Carton-100 (Carton 100)

Packaging label for PHYRAGO 100 mg tablets containing dasatinib. The label indicates 30 tablets per package, with warnings that it is a hazardous drug and instructions not to crush, cut, or chew the tablets. It is manufactured for Cycle Pharmaceuticals Ltd in Cambridge, UK, and storage instructions specify controlled room temperature between 20°C and 25°C with permitted excursions. The label features multiple barcodes and an FDA NDC number 70709-155-10.*

FDA Label Image

Carton-140 (Carton 140)

PHYRAGO 140 mg (dasatinib) tablets packaging label for oral use. The label indicates a 30-tablet count and includes warnings stating it is a hazardous drug and instructions not to crush, cut, or chew tablets. Manufactured by Cycle Pharmaceuticals Ltd, Cambridge, UK. The label also shows storage instructions and dosage information reference to prescribing information.*

FDA Label Image

Core-20 (Carton 20)

Packaging label for PHYRAGO 20 mg tablets containing dasatinib. The label indicates 60 tablets per container and displays warnings that the drug is hazardous and tablets should not be crushed, cut, or chewed but swallowed whole. Manufactured for Cycle Pharmaceuticals Ltd, Cambridge, UK, the label includes storage instructions and a barcode.*

FDA Label Image

Carton-50 (Carton 50)

PHYRAGO 50 mg tablets packaging label for prescription use. The label indicates that each tablet contains 50 mg of dasatinib. The package contains 60 tablets and includes warnings that it is a hazardous drug and instructions not to crush, cut, or chew tablets. The labeler is Cycle Pharmaceuticals Ltd, Cambridge, UK. Storage instructions are also provided, specifying temperature ranges.*

FDA Label Image

Carton-70 (Carton 70)

PHYRAGO 70 mg tablets packaging label for dasatinib oral tablets. The label indicates 60 tablets per bottle, with warnings about the drug being hazardous and instructions not to crush, cut, or chew tablets. The labeler is Cycle Pharmaceuticals Ltd, Cambridge, UK. Storage temperature guidance and a barcode are also visible.*

FDA Label Image

Carton-80 (Carton 80)

PHYRAGO 80 mg (dasatinib) tablets packaging label for oral administration. The label indicates 30 tablets per container and includes warnings that the product is a hazardous drug and instructions not to crush, cut, or chew the tablets but to swallow them whole. The label also provides storage instructions, manufacturer information for Cycle Pharmaceuticals Ltd in Cambridge, UK, and dosage referencing the prescribing information.*

FDA Label Image

Label-100 (Label 100)

Label for PHYRAGO (dasatinib) 100 mg tablets, showing a bottle containing 30 tablets. The label includes warnings not to crush, cut, or chew the tablets and indicates prescription use only. Manufactured by Cycle Pharmaceuticals Ltd in Cambridge, UK. The NDC number is 70709-155-10.*

FDA Label Image

Label-140 (Label 140)

Label for PHYRAGO (dasatinib) tablets 140 mg from Cycle Pharmaceuticals Ltd. The label indicates a bottle containing 30 tablets. It features warnings not to crush, cut, or chew the tablets and advises swallowing tablets whole. Storage instructions specify controlled room temperature with allowable excursions. The label includes the NDC 70709-156-14 and manufacturer location in Cambridge, UK.*

FDA Label Image

Label-20 (Label 20)

Label for PHYRAGO (dasatinib) 20 mg tablets showing the tablet count of 60 and NDC 70709-151-20. The label includes a warning that it is a hazardous drug and instructs to swallow tablets whole without crushing, cutting, or chewing. Manufactured by Cycle Pharmaceuticals Ltd, Cambridge, UK, with storage instructions and dosage advice included.*

FDA Label Image

Label-50 (Label 50)

Label for PHYRAGO (dasatinib) 50 mg tablets, an oral prescription drug. The label indicates a bottle containing 60 tablets, manufactured by Cycle Pharmaceuticals Ltd, UK. It includes a warning not to crush, cut, or chew the tablets and directs to swallow tablets whole. Storage instructions and dosage referencing are also noted.*

FDA Label Image

Label-70 (Label 70)

Label for PHYRAGO 70 mg tablets containing dasatinib, an oral prescription drug by Cycle Pharmaceuticals Ltd. The label indicates a 60-tablet count, a warning not to crush, cut, or chew tablets, and storage instructions. Includes NDC 70709-153-70 and barcode.*

FDA Label Image

Label-80 (Label 80)

Label for PHYRAGO (dasatinib) 80 mg tablets, oral dosage form by Cycle Pharmaceuticals Ltd. The label shows a bottle containing 30 tablets with a warning that it is a hazardous drug and instructs not to crush, cut, or chew tablets but to swallow them whole. It includes storage instructions and prescription-only status.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of dasatinib, the active ingredient in PHYRAGO. The image displays the molecular arrangement including rings, nitrogen atoms, chlorine, oxygen, and sulfur atoms consistent with the dasatinib structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.